How does mesalamine work in the gut?
Mesalamine (5-aminosalicylic acid, 5-ASA) is an anti-inflammatory medicine used mainly for ulcerative colitis and other 5-ASA–responsive inflammatory bowel conditions. Its key mechanism is local action in the intestinal lining to reduce intestinal inflammation. It acts primarily within the gut rather than systemically.
A central part of its anti-inflammatory effect is decreasing production of inflammatory mediators, including prostaglandins and leukotrienes, by interfering with pathways that drive their synthesis. Mesalamine also helps reduce mucosal oxidative stress and suppresses inflammatory signaling involved in recruiting and activating immune cells in the intestinal wall.
What molecular targets or pathways are involved?
Mesalamine’s effects are commonly described as downregulation of inflammatory eicosanoid pathways (prostaglandins and leukotrienes) and modulation of oxidative stress in the colonic mucosa. These actions collectively lead to reduced inflammatory activity at the site of disease, which is why it can relieve symptoms and help maintain remission in ulcerative colitis.
It is also associated with changes in immune activity in the intestinal mucosa, including reduced production of pro-inflammatory signals that perpetuate the inflammatory cycle.
Does mesalamine act systemically like steroids?
No. Mesalamine is designed for local delivery to the intestinal mucosa (for example, via delayed-release or pH-dependent formulations). That local action is a big part of how it differs from systemic anti-inflammatory drugs like corticosteroids: mesalamine aims to treat the inflammation at the tissue level where it occurs.
How formulation affects where it works
Because mesalamine needs to reach the colon or specific regions of the intestine to act locally, drug formulations matter. Common formulation types are designed to delay release until mesalamine reaches the intended segment of the GI tract, which improves local exposure and reduces unnecessary systemic effects.
What clinicians mean when they say “local anti-inflammatory”
In practice, “local anti-inflammatory” means mesalamine reduces inflammation-related mediators and oxidative injury in the intestinal mucosa, leading to symptom improvement (such as less rectal bleeding and stool frequency) and helping prevent flare-ups in patients whose disease responds to 5-ASA.
Sources
No sources were provided with your question. If you share a reference (label, guideline, or article), I can tailor the mechanism description to match that document exactly and cite it.